By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the injectable opioid agonist treatment (iOAT) models of care currently operating in Canada,
2) identify the key stakeholders and what pre-implementation consultation is required when starting an iOAT program,
3) describe the key staffing activities required in the provision of iOAT, and
4) incorporate patient perspective into care provision.